Flash glucose monitoring in young people with type 1 diabetes-a qualitative study of young people, parents and health professionals: '


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 04 2023
Historique:
medline: 21 4 2023
pubmed: 20 4 2023
entrez: 19 04 2023
Statut: epublish

Résumé

Flash glucose monitoring for patients with T1 diabetes avoids frequent painful finger-prick testing, thus potentially improving frequency of glucose self-monitoring. Our study aimed to explore experiences of young people using Freestyle Libre sensors and their parents, and to identify benefits and challenges to National Health Service (NHS) staff of its adoption in their care provision. Young people with T1 diabetes, their parents and healthcare professionals were interviewed between February and December 2021. Participants were recruited via social media and through NHS diabetes clinic staff. Semistructured interviews were conducted online and analysed using thematic methods. Staff themes were mapped onto normalisation process theory (NPT) constructs. Thirty-four participants were interviewed: 10 young people, 14 parents and 10 healthcare professionals. Young people reported that life was much easier since changing to flash glucose monitoring, increasing confidence and independence to manage their condition. Parents' quality of life improved and they appreciated access to real-time data. Using the NPT concepts to understand how technology was integrated into routine care proved useful; health professionals were very enthusiastic about flash glucose monitoring and coped with the extra data load to facilitate more tailored patient support within and between clinic visits. This technology empowers young people and their parents to understand their diabetes adherence more completely; to feel more confident about adjusting their own care between clinic appointments; and provides an improved interactive experience in clinic. Healthcare teams appear committed to delivering improving technologies, acknowledging the challenge for them to assimilate new information required to provide expert advice.

Identifiants

pubmed: 37076165
pii: bmjopen-2022-070477
doi: 10.1136/bmjopen-2022-070477
pmc: PMC10124239
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e070477

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Pediatr Diabetes. 2022 Dec;23(8):1270-1276
pubmed: 36537523
BMC Med. 2010 Oct 20;8:63
pubmed: 20961442
Prim Care Diabetes. 2019 Feb;13(1):63-70
pubmed: 30268507
J Diabetes Metab Disord. 2019 Dec 07;19(1):37-46
pubmed: 32550154
Pediatr Diabetes. 2022 Dec;23(8):1157-1159
pubmed: 36537535
Diabetes Metab Syndr. 2019 Sep - Oct;13(5):2923-2926
pubmed: 31425957
BMJ Open Diabetes Res Care. 2017 Feb 17;5(1):e000320
pubmed: 28243449
Pediatr Diabetes. 2022 Sep;23(6):799-808
pubmed: 35561092
Diabet Med. 2020 Apr;37(4):657-664
pubmed: 31769551

Auteurs

Lucy Beasant (L)

Centre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK.

Freyja Cullen (F)

Children's Diabetes Support, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK.

Elizabeth Thomas (E)

Children's Diabetes Support, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK.

Rebecca Kandiyali (R)

Centre for Health Economics, Warwick Medical School, Coventry, UK.

Julian P H Shield (JPH)

Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

David Mcgregor (D)

Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

Nicol West (N)

Great Western Hospitals NHS Foundation Trust, Swindon, UK.

Jenny Ingram (J)

Centre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK jenny.ingram@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH